BACHADON BOʻYNI SARATONINING OʻZBEKISTONDAGI TARQALISHI: KASALLANISH VA OʻLIM
##article.subject##:
bachadon boʻyni saraton, kasallanish, oʻlim##article.abstract##
Maqsad: Soʻnggi 15 yil davomida Oʻzbekiston Respublikasida bachadon boʻyni saratoni boʻyicha asosiy statistik koʻrsatkichlarni tahlil qilish. Usullar: Tadqiqotning materiallari va usullari sifatida 2010–2024 yillar davomidagi davlat statistik hisobot shakli («Xavfli oʻsmalar bilan kasallanish toʻgʻrisida ma'lumot», 7-shakl) dan foydalanildi. Natijalar: Oʻzbekiston Respublikasida onkologik kasallanish umumiy strukturasida bachadon boʻyni saratoni (BBS) saraton kasalliklari ichida toʻrtinchi oʻrinni egallab, koʻkrak bezi saratoni, yoʻgʻon ichak saratoni va me'da saratonidan keyin turadi. 15 yillik davr mobaynida BBS bilan kasallanganlar sonining tahlili shuni koʻrsatdiki, Respublika hududida barcha xavfli oʻsmalarning (XOʻ) ichida jami 23 668 ta BBS holati (6,9%) aniqlangan. Soʻnggi 15 yilda BBS bilan kasallanish koʻrsatkichi ortib borish tendensiyasiga ega boʻlib, 2010 yilda 100 000 ayol aholiga nisbatan 8,7 ni tashkil etgan boʻlsa, 2024 yilga kelib 11,1 ga etgan. Oʻzbekiston Respublikasida BBS bilan kasallanganlarning asosiy yosh toifasi 45–64 yoshdagi bemorlar boʻlib, ular ulushi 61,5% ni tashkil etgan. 2010–2024 yillar davomida Respublika boʻylab bachadon boʻyni xavfli oʻsmalari tufayli 12 412 nafar ayol vafot etgan. Shu davrda 100 000 ayol aholiga nisbatan oʻlim koʻrsatkichi 2010 yilda 4,4 ni tashkil etgan boʻlsa, 2024 yilda 4,9 ga etgan. Xulosa: Yuqorida keltirilgan ma'lumotlarga koʻra, BBS bilan kasallanish koʻrsatkichi Oʻzbekiston Respublikasida oʻsish tendensiyasiga ega va u ayollar aholisi oʻlimida etakchi sabablardan biri hisoblanadi. Shu bois, mazkur patologiyaga qarshi oʻz vaqtida samarali choralar koʻrish zarur.
Библиографические ссылки
Lawson H.W, Henson R, Bobo JK, Kaeser MK. Implementing recommendations for the early detection of breast and cervical cancer among low-income women. MMWR Recomm Rep. 2000 Mar 31;49(RR-2):37-55. PMID: 15580731.
IARC/WHO. Uzbekistan – Cervical Cancer Elimination Profile, March 2025
Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229‐263.
Filho A.M, Laversanne M, Ferlay J, Colombet M, Piñeros M, Znaor A, Parkin DM, Soerjomataram I, Bray F. The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide. Int J Cancer. 2025 Apr 1;156(7):1336-1346. doi: 10.1002/ijc.35278. Epub 2024 Dec 17. PMID: 39688499.
Rim C.H. et al. Comparison of Breast Cancer and Cervical Cancer in Uzbekistan and Korea: The First Report of the Uzbekistan–Korea Oncology Consortium. – Asian Pacific Journal of Cancer Prevention, 2022. – Vol. 23(10). – P. 3367–3374.
Ryzhov A, Corbex M, Piñeros M, Barchuk A, Andreasyan D, Djanklich S, Ghervas V, Gretsova O, Kaidarova D, Kazanjan K, Mardanli F, Michailovich Y, Ten E, Yaumenenka A, Bray F, Znaor A. Comparison of breast cancer and cervical cancer stage distributions in ten newly independent states of the former Soviet Union: a population-based study. Lancet Oncol. 2021 Mar;22(3):361-369. doi: 10.1016/S1470-2045(20)30674-4. Epub 2021 Feb 5. PMID: 33556324; PMCID: PMC8014987.
Sattorov A.Kh. Statistics and prognosis of cervical cancer in Uzbekistan over the past 10 years // Journal of modern medicine No. 2 (9), 2025. P 425-433. file:///C:/Users/Statistika/Downloads/_.._files_681efd640fbdb%20(1).pdf. (in Russ)
State statistical reporting forms of the Ministry of Health of the Republic of Uzbekistan "Information on malignant neoplasms" - form № 7 for 2010-2024. (in Russ)
The state of oncological care for the population of the Republic of Uzbekistan in 2023 / edited by M.N. Tillashaykhov, Sh.N. Ibragimov, S.M. Djanklich. - Tashkent: Halk Publishing House, 2024. - 178 p. (in Russ)
The state of oncological care for the population of the Republic of Uzbekistan in 2024 / edited by M.N. Tillashaykhov, Sh.N. Ibragimov, S.M. Djanklich. - Tashkent: Halk Publishing House, 2025. - 184 p. (in Russ)
Wang J, Lv H, Xue Z, Wang L, Bai Z. Temporal Trends of Common Female Malignances on Breast, Cervical, and Ovarian Cancer Mortality in Japan, Republic of Korea, and Singapore: Application of the Age-Period-Cohort Model. Biomed Res Int. 2018 Mar 21;2018:5307459. doi: 10.1155/2018/5307459. PMID: 29750160; PMCID: PMC5884400.
Znaor A, Ryzhov A, Losada ML, Carvalho A, Smelov V, Barchuk A, Valkov M, Ten E, Andreasyan D, Zhizhilashvili S, Dushimova Z, Zhuikova LD, Egorova A, Yaumenenka A, Djanklich S, Tril O, Bray F, Corbex M. Breast and cervical cancer screening practices in nine countries of Eastern Europe and Central Asia: A population-based survey. J Cancer Policy. 2023 Dec;38:100436. doi: 10.1016/j.jcpo.2023.100436. Epub 2023 Aug 5. PMID: 37544479; PMCID: PMC10695765.
Alkhathami, A. G., Altalbawy, F. M. A., Rizaev, J. A., Jeddoa, Z. M. A., & Jabir, M. S. (2025). An overview of lncRNA GAPLINC's role in human cancer growth and metastasis. Archives of Biochemistry and Biophysics, 110506.
Rizaev Jasur , Norbutayev Alisher, Murtazayev Alisher . Modern methods for detecting oral cavity defects in hemoblastosis , detecting the degree of damage and prediction of the clinical current. Journal of Biomedicine and Practice. 2021, vol. 6, issue 5, pp. 45-51
Shakhanova, S. S., Abdurakhmonov, J. A., & Rakhimov, N. M. (2023). Targeted therapy in the palliative treatment of platinum-resistant recurrent ovarian cancer complicated by ascites. The American Journal of Medical Sciences and Pharmaceutical Research, 5(8), 1.
Rizaev, J. A., Rahimov, N. M., & Shakhanova, S. S. (2023). Prostate cancer morbidity and mortality among men in high-risk areas. Eurasian Medical Research Periodical, 18, 101–104.
